Research & Development

久久99re热在线播放久久青青草热超碰东京一本道综合网高通股价盘前大跌:跌幅超7%

發布時間︰

  “我喜歡別的……不過很難出現……”   雲瑯順著霍光指引的方向看去,發現白玉的這片地方隱隱發暗。久久99re热在线播放   “沒錯,官府的事情做完了,還可以給商賈,富戶做事情,這個地方,所有的人都有家產,這是不合適的,總需要一些一無所有的人來做工。”久久青青草热超碰   “不看底下,我要你干什麼?”   這方面,他們很在行。东京一本道综合网   當雲哲的腦袋再一次出現在他窗戶上的時候,張安世嘆口氣道︰“有什麼話就說。”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.


Connect? Registries


The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo